- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1550-7416
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Defining Patient Centric Pharmaceutical Drug Product Design ; day:17 ; month:6 ; year:2016 ; pages:1-9
The AAPS journal / American Association of Pharmaceutical Scientists ; (17.6.2016), 1-9
- Creator
-
Stegemann, Sven
- Contributor
-
Ternik, Robert L.
Onder, Graziano
Khan, Mansoor A.
Riet-Nales, Diana A. Van
SpringerLink (Online service)
- DOI
-
10.1208/s12248-016-9938-6
- URN
-
urn:nbn:de:1111-201606198238
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stegemann, Sven
- Ternik, Robert L.
- Onder, Graziano
- Khan, Mansoor A.
- Riet-Nales, Diana A. Van
- SpringerLink (Online service)
Other Objects (12)
Future Perspectives for Patient-Centric Pharmaceutical Drug Product Design with Regard to Solid Oral Dosage Forms
Establishing Patient Centric Specifications for Drug Substance and Drug Product Impurities
Defining Cases and Variants for Object-Centric Event Data
Customer-centric product presentations for monoclonal antibodies
Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China
Structural Cheminformatics for Kinase-Centric Drug Design
Defining centric diatoms of most relevant phytoplankton functional groups in deep karst lakes
Primate models in pharmaceutical drug development
Advertising regulations in pharmaceutical markets: Product versus enlightenment
A strategic management perspective on service transition of product-centric firms
An enterprise centric analytical risk assessment framework for new product development
Building Natural Product–Based Libraries for Drug Discovery: Challenges and Opportunities from a Brazilian Pharmaceutical Industry Perspective
Future Perspectives for Patient-Centric Pharmaceutical Drug Product Design with Regard to Solid Oral Dosage Forms
Establishing Patient Centric Specifications for Drug Substance and Drug Product Impurities
Defining Cases and Variants for Object-Centric Event Data
Customer-centric product presentations for monoclonal antibodies
Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China
Structural Cheminformatics for Kinase-Centric Drug Design
Defining centric diatoms of most relevant phytoplankton functional groups in deep karst lakes
Primate models in pharmaceutical drug development
Advertising regulations in pharmaceutical markets: Product versus enlightenment
A strategic management perspective on service transition of product-centric firms
An enterprise centric analytical risk assessment framework for new product development
Building Natural Product–Based Libraries for Drug Discovery: Challenges and Opportunities from a Brazilian Pharmaceutical Industry Perspective
Future Perspectives for Patient-Centric Pharmaceutical Drug Product Design with Regard to Solid Oral Dosage Forms
Establishing Patient Centric Specifications for Drug Substance and Drug Product Impurities
Defining Cases and Variants for Object-Centric Event Data
Customer-centric product presentations for monoclonal antibodies
Evaluating the effect of artificial intelligence on pharmaceutical product and drug discovery in China
Structural Cheminformatics for Kinase-Centric Drug Design
Defining centric diatoms of most relevant phytoplankton functional groups in deep karst lakes
Primate models in pharmaceutical drug development
Advertising regulations in pharmaceutical markets: Product versus enlightenment
A strategic management perspective on service transition of product-centric firms
An enterprise centric analytical risk assessment framework for new product development